Labormed Posts 61% Higher Sales, 84% Lower Loss In 2013, 1st Year Under Alvogen’s Control

06.11.2014 By Ecaterina Craciun

Sales of Romanian generic drug producer Labormed Pharma surged nearly 61% to 141.8 million lei (EUR32 million) and its loss narrowed by 84% to RON18 million in 2013, the first year under the ownership of U.S. group Alvogen.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: LABORMED; , TURNOVER; , LOSS

Comment

Username:
Password: